Evidence map›Paper›PMID 26550155›Full record

ArticleInternational journal of clinical and experimental medicine2015

Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population.

Jianqiu Tang, Qiaoxia Zhou, Fen Zhao, Fulin Wei, Jian Bai, Yuping Xie, Ying Huang

Abstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 20 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. GSTM1 and GSTT1 Genetic Polymorphisms and Breast Cancer Risk in Selected Filipino CasesAsian Pacific journal of cancer prevention : APJCP · 2019
    Article
  10. The influence of anPharmacogenomics and personalized medicine · 2019
    Article
  11. Article
  12. Article
  13. No association betweenMolecular biology research communications · 2016
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jianqiu TangWest China School of Preclinical and Forensic Medicine, Sichuan University Chengdu 610041, Sichuan Province, China.
Qiaoxia ZhouWest China School of Preclinical and Forensic Medicine, Sichuan University Chengdu 610041, Sichuan Province, China.
Fen ZhaoDepartment of Oncology, Chengdu First People's Hospital Chengdu 610041, Sichuan Province, China.
Fulin WeiWest China School of Preclinical and Forensic Medicine, Sichuan University Chengdu 610041, Sichuan Province, China.
Jian BaiDepartment of Oncology, Chengdu First People's Hospital Chengdu 610041, Sichuan Province, China.
Yuping XieDepartment of Oncology, Chengdu First People's Hospital Chengdu 610041, Sichuan Province, China.
Ying HuangWest China School of Preclinical and Forensic Medicine, Sichuan University Chengdu 610041, Sichuan Province, China.
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPublished data regarding the associations between glutathione S-transferase (GST) T1, M1 and P1 polymorphisms and breast cancer risk are inconclusive. The aim of this study is to comprehensively evaluate the genetic risk of GST genes for breast cancer. MATERIALS AND

methodsA systematic literature search was carried out in Pubmed, Medline (Ovid), Embase, CBM, CNKI, Weipu, and Wanfang database, covering all publications (last search was performed on May 20, 2015). Statistical analysis was performed using Revman 5.2 and STATA 12.0 softwares.

resultsA total of 12,035 cases and 13,911 controls in 34 case-control studies were included in this meta-analysis. The results suggested that the GSTM1 and GSTP1 polymorphisms can obviously increase the risk of breast cancer in Asian population (odds ratio (OR) = 1.18, 95% confidence interval (CI) = 1.04-1.33, P = 0.008 and OR = 1.23, 95% CI = 1.07-1.41, P = 0.003, respectively), especially in East Asian (OR = 1.14, 95% CI = 1.01-1.27, P = 0.03 and OR = 1.15, 95% CI = 1.03-1.28, P = 0.01, respectively) and hospital-based case-control study (HCC) group (OR = 1.32, 95% CI = 1.11-1.56, P = 0.001 and OR = 1.38, 95% CI = 1.03-1.84, P = 0.03, respectively), while the association between GSTT1 null genotype and breast cancer risk is not significant (OR = 1.08, 95% CI = 0.93-1.25, P = 0.3).

conclusionsThis meta-analysis indicated that the GSTM1 and GSTP1 polymorphisms might significantly contribute to breast cancer susceptibility in Asian population, especially in East Asian, while the GSTT1 polymorphism might not be associated with breast cancer.

Indexed as

breast cancerGSTM1GSTP1GSTT1meta-analysispolymorphismsusceptibility

Identifiers

PMID26550155
PMCPMC4612840
OpenAlexW2312482229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.